Literature DB >> 9499421

Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein.

C Cardoso1, S Timsit, L Villard, M Khrestchatisky, M Fontès, L Colleaux.   

Abstract

Mutations in the XNP gene result in different inherited disorders, including the ATR-X syndrome which is characterized by mental retardation (MR) associated with alpha-thalaessemia. Amino acid sequence analysis revealed that the XNP protein is a new member of the SNF2-like family, which comprises numerous members involved in a broad range of biological functions: transcriptional regulation, DNA repair and chromosome segregation. Since experiments on fibroblasts from ATR-X patients have provided no evidence for either a DNA repair defect or abnormal chromosome breakage or segregation, it seems more likely that the XNP protein is somehow involved in regulation of gene expression. Recent genetic and biochemical studies have led to the emerging concept that SNF2-like proteins are components of a large protein complex which may exert its functions by modulating chromatin structure. To investigate whether XNP could mediate the activity of gene-specific activators through chromatin remodelling, we performed a yeast two-hybrid analysis using XNP and several human heterochromatin-associated proteins. We found a specific interaction between the XNP and the EZH2 proteins. In light of these observations, we discuss how the XNP protein may regulate gene transcription at the chromatin level.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9499421     DOI: 10.1093/hmg/7.4.679

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  41 in total

1.  The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies.

Authors:  Yutong Xue; Richard Gibbons; Zhijiang Yan; Dafeng Yang; Tarra L McDowell; Salvatore Sechi; Jun Qin; Sharleen Zhou; Doug Higgs; Weidong Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-02       Impact factor: 11.205

2.  Refinement of the genetic cause of ATR-16.

Authors:  Cornelis L Harteveld; Marjolein Kriek; Emilia K Bijlsma; Zoran Erjavec; Deepak Balak; Marion Phylipsen; Astrid Voskamp; Emmanora di Capua; Stefan J White; Piero C Giordano
Journal:  Hum Genet       Date:  2007-06-28       Impact factor: 4.132

3.  A trithorax-group complex purified from Saccharomyces cerevisiae is required for methylation of histone H3.

Authors:  Peter L Nagy; Joachim Griesenbeck; Roger D Kornberg; Michael L Cleary
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

4.  The ATRX-ADD domain binds to H3 tail peptides and reads the combined methylation state of K4 and K9.

Authors:  Arunkumar Dhayalan; Raluca Tamas; Ina Bock; Anna Tattermusch; Emilia Dimitrova; Srikanth Kudithipudi; Sergey Ragozin; Albert Jeltsch
Journal:  Hum Mol Genet       Date:  2011-03-18       Impact factor: 6.150

5.  ATRX directs binding of PRC2 to Xist RNA and Polycomb targets.

Authors:  Kavitha Sarma; Catherine Cifuentes-Rojas; Ayla Ergun; Amanda Del Rosario; Yesu Jeon; Forest White; Ruslan Sadreyev; Jeannie T Lee
Journal:  Cell       Date:  2014-11-06       Impact factor: 41.582

Review 6.  Histone regulation in the CNS: basic principles of epigenetic plasticity.

Authors:  Ian Maze; Kyung-Min Noh; C David Allis
Journal:  Neuropsychopharmacology       Date:  2012-07-25       Impact factor: 7.853

7.  UpSET-ting the balance: modulating open chromatin features in metazoan genomes.

Authors:  Hector Rincon-Arano; Susan M Parkhurst; Mark Groudine
Journal:  Fly (Austin)       Date:  2013-05-06       Impact factor: 2.160

Review 8.  Alternative lengthening of telomeres phenotype and loss of ATRX expression in sarcomas.

Authors:  Xiaolei Ren; Chao Tu; Zhenchu Tang; Ruofei Ma; Zhihong Li
Journal:  Oncol Lett       Date:  2018-03-22       Impact factor: 2.967

Review 9.  ATRX: the case of a peculiar chromatin remodeler.

Authors:  Kajan Ratnakumar; Emily Bernstein
Journal:  Epigenetics       Date:  2012-12-18       Impact factor: 4.528

10.  Decreased expression of GRAF1/OPHN-1-L in the X-linked alpha thalassemia mental retardation syndrome.

Authors:  Vincenza Barresi; Angela Ragusa; Marco Fichera; Nicolò Musso; Lucia Castiglia; Giancarlo Rappazzo; Salvatore Travali; Teresa Mattina; Corrado Romano; Guido Cocchi; Daniele F Condorelli
Journal:  BMC Med Genomics       Date:  2010-07-06       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.